LACTATED RINGER'S IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).

How it works

Lactated Ringer's solution provides isotonic crystalloid fluids that expand intravascular volume and replace fluid and electrolyte deficits. Its components (sodium, chloride, potassium, calcium, and lactate) restore extracellular fluid composition. Lactate is metabolized to bicarbonate in the liver, providing a buffer to correct metabolic acidosis.

What the body does with it

Metabolism	Lactate is primarily metabolized by the liver (oxidation to pyruvate and gluconeogenesis) and to a lesser extent by kidneys and heart. Bicarbonate is generated via the Cori cycle.
Excretion	Renal: >95% (primarily lactate metabolism to bicarbonate, but electrolytes and water are excreted renally); Biliary/Fecal: negligible.
Half-life	Not applicable for a solution; the infused crystalloid distributes and is eliminated with a distribution half-life of 15-30 minutes and a terminal elimination half-life of 1-2 hours for the water component.
Protein binding	None (lactate and electrolytes are not protein-bound; essentially 0% bound).
Volume of Distribution	0.2-0.3 L/kg (confined to extracellular fluid; approximately 20-30% of body weight).
Bioavailability	Intravenous: 100%.
Onset of Action	Intravenous: Immediate (within seconds to minutes) for volume expansion and electrolyte effects.
Duration of Action	Intravenous: Volume effect lasts 30-60 minutes; electrolyte effects persist while infused and shortly after.

Classification & Brands

Dosing & administration

Intravenous infusion; typical adult dose 500-1000 mL as a single dose, rate 30-40 mL/kg/24 hours with careful monitoring of fluid and electrolyte status.

Dosage form	SOLUTION
Renal impairment	Contraindicated or use with extreme caution in renal failure; avoid in severe renal impairment (eGFR <30 mL/min) due to risk of hyperkalemia and fluid overload; consider alternative fluids.
Liver impairment	Use with caution in hepatic impairment; no specific dose adjustment recommended, but monitor for lactic acidosis in severe hepatic dysfunction (Child-Pugh C).
Pediatric use	Weight-based: Initial dose 20-30 mL/kg, then maintenance 100-150 mL/kg/day for small children, adjusted based on clinical response and serum electrolyte monitoring.
Geriatric use	Elderly: Use with caution due to potential for fluid overload, renal impairment, and electrolyte disturbances; adjust rate and volume based on renal function and cardiac status; typical starting rate 20-30 mL/kg/24 hours.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).

Breastfeeding	Compatible with breastfeeding. Components (sodium, chloride, potassium, calcium, lactate) are normal plasma constituents. M/P ratio not applicable as solution components are endogenous. No adverse effects on nursing infant expected when used as directed.
Teratogenic Risk	No evidence of teratogenicity from balanced crystalloid solutions. Lactated Ringer's is isotonic and contains electrolytes and lactate at physiologic concentrations. No fetal risk identified with standard use during any trimester. Administration of large volumes may cause maternal fluid overload, electrolyte disturbances, or acid-base imbalance, which could indirectly affect fetal homeostasis.

Warnings & precautions

■ FDA Black Box Warning

WARNING: Do not use for cardiopulmonary bypass or in neonates with elevated lactate levels. Contains calcium; co-administration with ceftriaxone may cause fatal precipitation. Do not administer with blood through same IV line due to risk of coagulation.

Side Effect Profile

Serious Effects

Absolute Contraindications

Hyperkalemia, hypercalcemia, severe metabolic alkalosis, severe lactic acidosis, patients receiving ceftriaxone (due to precipitation risk), and known hypersensitivity to any component.

Clinical Precautions

Precautions

Monitor for fluid overload, especially in renal impairment, heart failure, or pulmonary edema. Use caution in liver disease (lactate metabolism may be impaired). Avoid in severe metabolic alkalosis. May cause hyperkalemia in renal failure due to potassium content.

Clinical Tips & Counseling

Drug interactions

Loading safety data…

LACTATED RINGER'S IN PLASTIC CONTAINER

Clinical safety rating: caution

Comprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).

How it works

What the body does with it

Metabolism	Lactate is primarily metabolized by the liver (oxidation to pyruvate and gluconeogenesis) and to a lesser extent by kidneys and heart. Bicarbonate is generated via the Cori cycle.
Excretion	Renal: >95% (primarily lactate metabolism to bicarbonate, but electrolytes and water are excreted renally); Biliary/Fecal: negligible.
Half-life	Not applicable for a solution; the infused crystalloid distributes and is eliminated with a distribution half-life of 15-30 minutes and a terminal elimination half-life of 1-2 hours for the water component.
Protein binding	None (lactate and electrolytes are not protein-bound; essentially 0% bound).
Volume of Distribution	0.2-0.3 L/kg (confined to extracellular fluid; approximately 20-30% of body weight).
Bioavailability	Intravenous: 100%.
Onset of Action	Intravenous: Immediate (within seconds to minutes) for volume expansion and electrolyte effects.
Duration of Action	Intravenous: Volume effect lasts 30-60 minutes; electrolyte effects persist while infused and shortly after.

Classification & Brands

Dosing & administration

Intravenous infusion; typical adult dose 500-1000 mL as a single dose, rate 30-40 mL/kg/24 hours with careful monitoring of fluid and electrolyte status.

Dosage form	SOLUTION
Renal impairment	Contraindicated or use with extreme caution in renal failure; avoid in severe renal impairment (eGFR <30 mL/min) due to risk of hyperkalemia and fluid overload; consider alternative fluids.
Liver impairment	Use with caution in hepatic impairment; no specific dose adjustment recommended, but monitor for lactic acidosis in severe hepatic dysfunction (Child-Pugh C).
Pediatric use	Weight-based: Initial dose 20-30 mL/kg, then maintenance 100-150 mL/kg/day for small children, adjusted based on clinical response and serum electrolyte monitoring.
Geriatric use	Elderly: Use with caution due to potential for fluid overload, renal impairment, and electrolyte disturbances; adjust rate and volume based on renal function and cardiac status; typical starting rate 20-30 mL/kg/24 hours.

Use during pregnancy

1st trimester	Consult provider
2nd trimester	Consult provider
3rd trimester	Consult provider

Clinical note

Comprehensive clinical and safety monograph for LACTATED RINGER'S IN PLASTIC CONTAINER (LACTATED RINGER'S IN PLASTIC CONTAINER).

Breastfeeding	Compatible with breastfeeding. Components (sodium, chloride, potassium, calcium, lactate) are normal plasma constituents. M/P ratio not applicable as solution components are endogenous. No adverse effects on nursing infant expected when used as directed.
Teratogenic Risk	No evidence of teratogenicity from balanced crystalloid solutions. Lactated Ringer's is isotonic and contains electrolytes and lactate at physiologic concentrations. No fetal risk identified with standard use during any trimester. Administration of large volumes may cause maternal fluid overload, electrolyte disturbances, or acid-base imbalance, which could indirectly affect fetal homeostasis.

Warnings & precautions

■ FDA Black Box Warning

Side Effect Profile

Serious Effects

Absolute Contraindications

Hyperkalemia, hypercalcemia, severe metabolic alkalosis, severe lactic acidosis, patients receiving ceftriaxone (due to precipitation risk), and known hypersensitivity to any component.